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Although ventricular fibrillation is a well known sequel
to atrial fibrillation in the Wolff-Parkinson-White syn-
drome, ventricular fibrillation is not generally associated
with supraventricular tachycardia in the presence of en-
hanced atrioventricular (AV) node conduction without
pre-excitation. It was hypothesized that the ventricular
response during atrial fibrillation may be less in patients
with enhanced AV node conduction than in their coun-
terparts with Wolff-Parkinson-White syndrome matched
for anterograde effective refractory period. Slower ven-
tricular rates during atrial fibrillation would suggest an
increased propensity for concealed conduction in the en-
hanced AV node conduction group than in the group
with an accessory pathway.
Three groups of patients aged 16 to 65 years under-
went electrophysiologic testing for supraventricular
tachycardia or after surgical correction of Wolff-Par-
kinson-White syndrome. Sixteen patients had enhanced
AV node conduction, 16 had Wolff-Parkinson-White
syndrome and 16 had normal AV node conduction. Pa-
Ventricular fibrillation is a well known sequel to atrial fi-
brillation in the Wolff-Parkinson-White syndrome (1-4),
but it has only been sporadically reported in association with
supraventricular arrhythmias in patients without Wolff-Par-
kinson- White syndrome even in the presence of enhanced
atrioventricular (AV) node conduction (5-9). Concealed
conduction in the AV node is known to play an important
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tients with enhanced AV node conduction and Wolff-
Parkinson-White syndrome were well matched for an-
terograde effective refractory period (245 ± 22 versus
258 ± 25 ms) and minimal cycle length, maintaining
1: 1 anterograde conduction (261 ± 21 versus 260 ±
40). There was no difference in intervals during atrial
fibrillation (average RR interval = 372 ± 37 versus 346
± 66) or shortest RR interval (266 ± 27 versus 243 ±
51).
Thus, patients with Wolff-Parkinson-White syn-
drome and those with enhanced AV node conduction
matched for anterograde refractory period exhibit sim-
ilar ventricular rates during atrial fibrillation. Because
concealed conduction is an important determinant of the
ventricular response during atrial fibrillation, the latter
suggests that our patients with enhanced AV node con-
duction did not exhibit a greater propensity for con-
cealed conduction than did patients with an accessory
AV pathway matched for refractoriness.
(J Am Coil CardioI1987;1O:1244-8)
role in the ventricular response during atrial fibrillation (10).
We hypothesized that the ventricular response during atrial
fibrillation may be less in patients with enhanced AV node
conduction than in patients with Wolff- Parkinson-White
syndrome, possibly because of greater potential for con-
cealed conduction in the larger and complex AV node than
in the simple muscular strands of accessory AV pathways.
To test this hypothesis, we compared the ventricular rate
during atrial fibrillation in patients with enhanced AV node
conduction to the rate in patients with pre-excited QRS
complexes during atrial fibrillation in the Wolff-Parkinson-
White syndrome. Patients with this syndrome were matched
to have anterograde effective refractory periods of the ac-
cessory pathway comparable with the anterograde effective
refractory periods of the AV node in the group with en-
hanced AV node conduction. A control group of patients
with normal AV node conduction was also studied.
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Methods
Study patients. Three groups of patients were studied:
Group A, 16 patients (4 men, 12 women), ranging in age
froni 16 to 57 years (mean 29) with enhanced AV node
conduction; Group B, 16 patients (9 men, 7 women), rang-
ing in age from 16 to 50 years (mean 28) with Wolff-
Parkinson-White syndrome; and Group C, 16 patients (8
men, 8 women), ranging in age from 18 to 65 years (mean
38) with normal AV node conduction and no pre-excitation.
Group A consisted of 12 patients studied 7 to 10 days
after surgery for the Wolff-Parkinson-White syndrome, 2
patients referred for electrophysiologic study for supraven-
tricular arrhythmias associated with a concealed accessory
pathway, I patient with AV node reentry and I patient with
ventricular tachycardia. Group B consisted of 16 patients
referred for elecirophysiologic study because of Wolff-Par-
kinson- White syndrome and were selected to match the an-
terograde effective refractory period of the accessory path-
way with that of the AV node in Group A. These patients
had a predominantly pre-excited QRS complex (~98%) dur-
ing atrial fibrillation. Four of the Group B patients were
also studied postoperatively and were included in Group A.
Group C was used as a control group (n = 16) and consisted
of patients studied 1 week after Wolff-Parkinson-White syn-
drome surgery (n = 8) and those studied for miscellaneous
indications, including AV node reentry (n = 3), syncope
(n = 2), ventricular tachycardia (n = 1) and sick sinus
syndrome (n = 2). These patients did not fulfill the criteria
for enhanced AV node conduction (5).
Electrophysiologic study. All patients were studied in
the nonsedated, postabsorptive state after all antiarrhythmic
medication had been discontinued for at least five drug half-
lives. The method of studying patients with pre-excitation
in our laboratory has been described (II). Postoperative
patients were studied 1 week after surgery using epicardial
wires to pace the right atrium and right ventricle, and the
remaining groups were studied using endocardial catheters
at the high right atrium, right ventricular apex and across
the tricuspid valve for His bundle recording. Electrophys-
iologic testing in all patients included incremental atrial and
ventricular pacing and right atrial and right ventricular ex-
trastimulus testing at two cycle lengths (generally 600 and
400 ms). Atrial fibrillation was induced by rapid atrial pac-
ing when it did not occur during the course of the study.
In some patients, atrial fibrillation could be maintained only
by rapid atrial pacing. Intervals were measured over a I
minute sample of atrial fibrillation and included the shortest,
the longest and the average RR interval between consecutive
pre-excited or normal beats.
Standard definitions were used for refractory periods of
the' accessory pathway and the AV node (12). Enhanced
AV node conduction was defined as I: I conduction main-
tained to a pacing cycle length ::s 300 ms with total AV
conduction prolongation ::s 100 ms as compared with sinus
rhythm (5).
We defined a "concealment index" as the difference
between the longest and the shortest RR interval between
consecutive pre-excited or normal beats. This definition was
chosen because the shortest RR interval correlates reason-
ably well with the anterograde effective refractory period.
and the long RR intervals, during atrial fibrillation, result
largely from the influences of concealed conduction
00,13,14). The measured index correlates well with pro-
longation of the effective refractory period of an accessory
pathway due to concealment of a previous extrastimulus
blocked at the effective refractory period of the pathway
(3).
Results
Anterograde effective refractory period. Patients with
Wolff-Parkinson-White syndrome were selected to have an
anterograde effective refractory period of the accessory
pathway similar to the anterograde effective refractory pe-
riod of the AV node in the group with enhanced AV node
conduction (Table I, Fig. I). Patients with normal AV con-
duction had a longer anterograde effective refractory period
than that of the other two groups (Table I).
Table 1. Comparison of Electrophysiologic Measures in Three Patient Groups
Enhanced AVNC WPW Normal AVNC
(Group A) p Value" (Group B) p Value t (Group C)
ERP 245 ± 22 (NS) 258 ± 25 (0.001) 327 ± 78
SCL I; I 261 ± 21 (NSj 260 ± 40 (0.001) 383 ± 59
SRR 266 ± 27 (NS) 243 ± 51 (0.001) 386 ± 57
ARR 372 ± 37 (NS) 346 ± 66 (0.001) 533 ± 108
LRR 580 ± 103 (NS) 533 ± 87 (0.001 ) 871 ± 262
CI 314 ± 108 (NS) 288 ± 70 (0.02) 477 ± 247
*Comparison of Group A with Group B; tcomparison of Group C with Groups A and B.
ARR = average RR interval during atrial fibrillation; AVNC = atrioventricular node conduction; CI =
concealment index; ERP = effective refractory period (at drive cycle length 600 or 500 rns, anterograde); LRR
= longest RR interval; SCL I : I = shortest cycle length maintaining I to I anterograde conduction; SRR =
shortest RR interval; WPW = Wolff-Parkinson-White Syndrome.
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Figure1. Effective anterograde refractory period (ERP, drive cycle
length 600ms) isplotted forthethree groups. EAVNC = enhanced
AV node conduction; NAVNC = normal AV node conduction;
NS = notsignificant; WPW = Wolff-Parkinson-White syndrome. Figure 3. Average RR (ARR) intervals in atrial fibrillation for
the three groups. Abbreviations as in Figure 1.
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RR intervals: concealment index. The average RR in-
tervals and shortest RR intervals in atrial fibrillation did not
differ between patients with Wolff-Parkinson-White syn-
drome and those with enhanced AV node conduction (Fig.
2 and 3), but were greater in patients with normal AV node
conduction. The "concealment index," defined as the dif-
ference between the longest and the shortest RR intervals,
similarly did not differ in Wolff-Parkinson-White syndrome
and enhanced AV node conduction (Fig. 4).
Anterograde effective refractory period versus con-
cealment index. To examine the relation between effective
refractory period and the concealment index, anterograde
effective refractory period of the accessory pathway (Group
B) or AV node (Groups A and C) was plotted against the
concealment index (Fig. 5). A linear correlation was present
with a coefficient of correlation of 0.57 and a p value for
identity <0.005.
Figure 2. Shortest RR (SRR) intervals in atrial fibrillation for the
three groups. Abbreviations as in Figure 1.
Discussion
Ventricular fibrillation is a well known complication in
patients with the Wolff-Parkinson-White syndrome and a
rapid ventricular response over the accessory pathway in
atrial fibrillation. Although a similar incidence of ventricular
fibrillation may be expected to occur in patients with tachy-
cardia associated with enhanced AV node conduction or
Lown-Ganong-Levine syndrome, such is not the case. Ven-
tricular fibrillation in the latter patients is infrequently re-
ported and has occurred mainly in the context of organic
heart disease, myocardial ischemia or inducible ventricular
arrhythmias (5-8).
Role of concealed conduction in atrial fibrillation.
Concealed conduction has been demonstrated to be an im-
portant factor limiting the ventricular response during atrial
Figure 4. Concealment index (Cl) for the three patient groups
(difference between longest andshortest RR intervals during atrial
fibrillation). Abbreviations as in Figure I.
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Figure 6. Shortest RR interval (SRR) in atrial fibrillation ex-
pressed in milliseconds on Y axis . WPW-YF = Wolff-Parkinson-
White group having experiencedventricular fibrillation (from Ref.
4). The shortest RR intervals in the latter group areclearly shorter
than those in the other groups. most being ::s 200 ms.
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have an important role in precipitating atrial fibrillation
( 16.17). This is evidenced by the more frequent occurrence
of atrial fibrillation in manifest as opposed to concealed
Wolff-Parkinson-White syndrome and also by the preven-
tion of atrial fibrillation after accessory pathway ablation
(16.18). Second. asynchronous activation of the ventricles
over one or more accessory pathways during atrial fibril-
lation in the Wolff-Parkinson-White syndrome would be
expected to be a more potent stimulus to precipitate ven-
tricular fibrillation than would activation over the normal
AV conduction system. Finally. most patients with en-
hanced AV node conduction may simply not have the very
short refractory periods and rapid ventricular responses dur-
ing atrial fibrillation observed in patients with an accessory
pathway who have sustained ventricular fibrillation(Fig. 6).
It is apparent from Figures I to 4 that a great deal of
overlap exists between the indexes of AV node fun ction in
our three groups ofpatients . Patients with Wolff-Parkinson-
White syndrome were selected to match patients with en-
hanced AV node conduction on the basis of a similar ef-
fective refractory period. A reasonable match, therefore,
exists between these groups in effective refractory period
and other indexes of AV node conduction. The group of
patients with " normal" AV node conduction is more ec-
lectic and includes patients with various degrees of AV node
disease and function. This is not surprising because the only
criterion for their selection was absence of the criteria for
enhanced AV node conduction. Because the criteria for
enhanced AV node conduction are empirical. one would
not expect a distinct separation between this group and oth-
ers with respect to all indexes of AV node function.
Limitations. A limitation of this study is the difficulty
in accurately "quantifyin g" the potential for single and
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Figure5. Effective refractory period (anterograde)(ERP) plotted
against concealment index (Cl) for all patients. Y = 0.215x +
202.9; R = 0.57; p < 0.005.
fibrill ation over both the normal AV conduction system (10)
and accessory pathways (13). An important determinant of
potential concealment into the AV node is the effective
refractory period. The longerthe refractory period, the longer
" the primary concealment zone" (14) and the greater the
probability of concealment during atrial fibrillation. The
significant although not striking correlation between our
concealment index and refractory period also supports this
view. The amount of concealment is also determined by the
atrial rate (10). Although atrial rate is impossible to deter-
mine during atrial fibrillation, the fibrillation rate would not
be expected to differ in patients with or without an accessory
pathway.
Another potential determinant of concealment examined
in this study is the type of tissue involved. The larger and
more complicated anatomy of the AV node (15) with slow
channel-dependent tissue may be expected to exhibit a greater
potential for concealment than the muscle strands making
up accessory AV pathways (15). The data in this study were
not compatible with this hypothesis. Ventricular responses
during atrial fibrillation and our measure of concealment
(the difference between the longest and shortest RR inter-
vals) were not different between patients with pre-excitation
and those with enhanced AV node conduction as long as
the refractory period of the accessory pathway and AV node
were comparable. As expected, patients with normal AV
node conduction and a longer refractory period had slower
ventricular responses during atrial fi brillation. It would.
therefore. appear that the degree of concealment and the
ventricular response during atrial fibrillation are dependent
not on the tissue used for AV conduction. but rather on the
refractory period of the tissue and other undefined factors.
Determinants of ventricular fibrillation in Wolff-Par-
kinson-White syndrome and in enhanced AV node con-
duction. Other factors may be responsible for the relatively
infrequent occurrence of ventricular fi brillation in tachy-
cardia associated with enhanced AV node conduction as
compared with the Wolff-Parkinson-White syndrome. First,
atrial fibrillation may not occur as frequently in supraven-
tricular tachycardia not associated with pre-excitation. An-
terograde conduction over an accessory pathway itself may
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repetitive concealment into either the AV node or accessory
pathway, We believe that the ventricular response during
atrial fibrillation is a reasonable reflection of potential for
concealment, especially under the baseline conditions of the
study. The concealment index is intuitively reasonable as a
measure of concealment in that the shortest RR interval
approximates the Wenckebach cycle length for both the AV
node (19) and the accessory pathway (18), and the longest
RR interval is dependent on concealment (10,13). In ad-
dition, the index has been shown to correlate with the in-
crease in refractoriness of an accessory pathway after an
extrastimulus that fails to conduct over the pathway (13).
Another potential limitation of this study is that many
patients with enhanced AV node conduction previously had
an overt or concealed AV pathway. It may be argued that
these are not representative of patients with enhanced AV
node conduction as a group. The criteria, however, for
enhanced AV node conduction in previous studies were
derived empirically on the basis of electrocardiographic and
electrophysiologic criteria, without regard to the presence
or absence of accessory pathways or the mechanism of con-
comitant arrhythmias. It is not known whether patients ful-
filling the criteria for enhanced AV node conduction have
a specific common morphologic substrate, and evidence for
this concept is certainly lacking. There is no reason to sus-
pect that the patients with enhanced AV node conduction
and one or more accessory pathways are different from those
patients with enhanced AV node conduction without an
accessory pathway.
We thank Sheila Doan for preparing the manuscript.
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